Deucravacitinib long-term efficacy with continuous treatment in plaque psoriasis: 2-year results from the phase 3 POETYK PSO program. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s118, 2023. DOI: 10.25251/skin.7.supp.118. Disponível em: https://skin.dermsquared.com/skin/article/view/1968. Acesso em: 20 apr. 2026.